Last 12 months
Inside the activity.
2 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 1 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 7 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 1 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 05, 2021 Filed Mar 9, 2021 17:36 UTC |
Khayal Tamer IChief Commercial Officer
|
Exercise / conversionCommon Stock | 5,452 | $0.28 | $1,526.56 |
DisclosureSEC source: 0000899243-21-010701 · doc4.xml · nonDerivative · entry 2 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,076 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 17:36 UTC |
Khayal Tamer IChief Commercial Officer
|
Exercise / conversionCommon Stock | 14,548 | $0.39 | $5,673.72 |
DisclosureSEC source: 0000899243-21-010701 · doc4.xml · nonDerivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,624 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 17:48 UTC |
Khayal Tamer IChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 70,000 | $0.00 Strike: $38.46 | $0.00 |
DisclosureSEC source: 0000899243-21-008448 · doc4.xml · derivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2031-02-24 F1 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 22:52 UTC |
Hassanein Waleed HDirector · President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 310,000 | $0.00 Strike: $38.46 | $0.00 |
DisclosureSEC source: 0000899243-21-008457 · doc4.xml · derivative · entry 1 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 310,000 Underlying: Common Stock · 310,000 shares Expires 2031-02-24 F1 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 22:53 UTC |
Gordon StephenChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 70,000 | $0.00 Strike: $38.46 | $0.00 |
DisclosureSEC source: 0000899243-21-008458 · doc4.xml · derivative · entry 1 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2031-02-24 F1 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 22:49 UTC |
Sullivan John FVP of Quality & Engineering
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $38.46 | $0.00 |
DisclosureSEC source: 0000899243-21-008450 · doc4.xml · derivative · entry 1 Sullivan John F · CIK 0001774273 · VP of Quality & Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2031-02-24 F1 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 22:51 UTC |
Carey John FVP of Operations
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $38.46 | $0.00 |
DisclosureSEC source: 0000899243-21-008456 · doc4.xml · derivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2031-02-24 F1 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 22:45 UTC |
Provost MiriamVP of US Regulatory & FDA Rel.
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $38.46 | $0.00 |
DisclosureSEC source: 0000899243-21-008444 · doc4.xml · derivative · entry 1 Provost Miriam · CIK 0001773663 · VP of US Regulatory & FDA Rel. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2031-02-24 F1 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 22:43 UTC |
DAMME LAURAVP, Clinical Affairs
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $38.46 | $0.00 |
DisclosureSEC source: 0000899243-21-008443 · doc4.xml · derivative · entry 1 DAMME LAURA · CIK 0001784433 · VP, Clinical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2031-02-24 F1 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 22:43 UTC |
Gordon StephenChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.67 | $0.00 |
DisclosureSEC source: 0000899243-21-006942 · doc4.xml · derivative · entry 3 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,713 Underlying: Common Stock · 10,000 shares Expires 2025-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 22:43 UTC |
Gordon StephenChief Financial Officer
|
SaleCommon Stock | 10,000 | $31.33 | $313,300.00 |
DisclosureSEC source: 0000899243-21-006942 · doc4.xml · nonDerivative · entry 2 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $31.00 to $31.82, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 22:43 UTC |
Gordon StephenChief Financial Officer
|
Exercise / conversionCommon Stock | 10,000 | $0.67 | $6,700.00 |
DisclosureSEC source: 0000899243-21-006942 · doc4.xml · nonDerivative · entry 1 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 09, 2021 Filed Feb 10, 2021 16:53 UTC |
ABRAMS CAPITAL MANAGEMENT, L.P.10% owner
ABRAMS CAPITAL MANAGEMENT, LLC10% owner
Abrams Capital Partners II, L.P.10% owner
ABRAMS CAPITAL, LLC10% owner
Abrams David C10% owner
Riva Capital Partners III, L.P.10% owner
Riva Capital Management III, LLC10% owner
|
SaleCommon Stock | 786,664 | $33.32 | $26,208,733.82 |
DisclosureSEC source: 0000899243-21-005693 · doc4.xml · nonDerivative · entry 2 ABRAMS CAPITAL MANAGEMENT, L.P. · CIK 0001358706 · 10% owner ABRAMS CAPITAL MANAGEMENT, LLC · CIK 0001165407 · 10% owner Abrams Capital Partners II, L.P. · CIK 0001292420 · 10% owner ABRAMS CAPITAL, LLC · CIK 0001112443 · 10% owner Abrams David C · CIK 0001292250 · 10% owner Riva Capital Partners III, L.P. · CIK 0001525135 · 10% owner Riva Capital Management III, LLC · CIK 0001775371 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 2,624,712 F5 · price: Represents the weighted average sale price of shares sold in a series of open market transactions on the transaction date at prices ranging from $33.04461 to $33.31643 per share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price. F2 · ownership.nature: Shares reported herein as beneficially owned by (i) Abrams Capital, LLC ("Abrams Capital") represent shares held for the account of Abrams Capital Partners II, L.P. ("ACP II") and other private investment funds for which Abrams Capital serves as general partner; and (ii) Riva Capital Management III, LLC ("RCM III") represent shares held for the account of Riva Capital Partners III, L.P. ("Riva III"), for which RCM III serves as general partner. Shares reported herein for Abrams Capital Management, L.P. (the "LP") and Abrams Capital Management, LLC (the "LLC") represent shares beneficially owned by private investment funds for which the LP serves as investment manager, including ACP II and Riva III. The LLC is the general partner of the LP. Shares reported herein for Mr. Abrams represent the above referenced shares reported for Abrams Capital, RCM III and the LLC. Mr. Abrams is the managing member of Abrams Capital, RCM III, and the LLC. F3 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or his pecuniary interest in such shares, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purpose. F6 · ownership.nature: Of the shares sold on February 9, 2021, 365,078 shares were held for the account of ACP II; 327,777 shares were held for the account of Riva III; RCM III may be deemed to beneficially own 327,777 shares; Abrams Capital may be deemed to beneficially own 432,043 shares; and all such shares may be deemed to have been beneficially owned by Mr. Abrams, the LP and the LLC. Read SEC document |
| February 09, 2021 Filed Feb 10, 2021 23:59 UTC |
TOBIN JAMES RDirector
|
SaleCommon Stock | 200 | $34.18 | $6,836.00 |
DisclosureSEC source: 0000899243-21-005746 · doc4.xml · nonDerivative · entry 2 TOBIN JAMES R · CIK 0001190128 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By the James R. Tobin 2012 Trust Disclosed balance after: 424,637 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 09, 2021 Filed Feb 10, 2021 23:59 UTC |
TOBIN JAMES RDirector
|
SaleCommon Stock | 9,968 | $32.80 | $326,950.40 |
DisclosureSEC source: 0000899243-21-005746 · doc4.xml · nonDerivative · entry 1 TOBIN JAMES R · CIK 0001190128 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By the James R. Tobin 2012 Trust Disclosed balance after: 424,837 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $32.50 to $33.30 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 13:57 UTC |
Sullivan John FVP of Quality & Engineering
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 8,600 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0000899243-21-005847 · doc4.xml · derivative · entry 4 Sullivan John F · CIK 0001774273 · VP of Quality & Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,600 shares Expires 2023-03-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 13:57 UTC |
Sullivan John FVP of Quality & Engineering
|
SaleCommon Stock | 200 | $34.18 | $6,836.00 |
DisclosureSEC source: 0000899243-21-005847 · doc4.xml · nonDerivative · entry 3 Sullivan John F · CIK 0001774273 · VP of Quality & Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,828 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 13:57 UTC |
Sullivan John FVP of Quality & Engineering
|
SaleCommon Stock | 8,400 | $32.78 | $275,352.00 |
DisclosureSEC source: 0000899243-21-005847 · doc4.xml · nonDerivative · entry 2 Sullivan John F · CIK 0001774273 · VP of Quality & Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,028 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $32.50 to $33.41 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 13:57 UTC |
Sullivan John FVP of Quality & Engineering
|
Exercise / conversionCommon Stock | 8,600 | $0.28 | $2,408.00 |
DisclosureSEC source: 0000899243-21-005847 · doc4.xml · nonDerivative · entry 1 Sullivan John F · CIK 0001774273 · VP of Quality & Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,428 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 16:53 UTC |
ABRAMS CAPITAL MANAGEMENT, L.P.10% owner
ABRAMS CAPITAL MANAGEMENT, LLC10% owner
Abrams Capital Partners II, L.P.10% owner
ABRAMS CAPITAL, LLC10% owner
Abrams David C10% owner
Riva Capital Partners III, L.P.10% owner
Riva Capital Management III, LLC10% owner
|
SaleCommon Stock | 88,483 | $26.24 | $2,321,705.44 |
DisclosureSEC source: 0000899243-21-005693 · doc4.xml · nonDerivative · entry 1 ABRAMS CAPITAL MANAGEMENT, L.P. · CIK 0001358706 · 10% owner ABRAMS CAPITAL MANAGEMENT, LLC · CIK 0001165407 · 10% owner Abrams Capital Partners II, L.P. · CIK 0001292420 · 10% owner ABRAMS CAPITAL, LLC · CIK 0001112443 · 10% owner Abrams David C · CIK 0001292250 · 10% owner Riva Capital Partners III, L.P. · CIK 0001525135 · 10% owner Riva Capital Management III, LLC · CIK 0001775371 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 3,411,376 F1 · price: Represents the weighted average sale price of shares sold in a series of open market transactions on the transaction date at prices ranging from $26.23646 to $26.2918 per share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price. F2 · ownership.nature: Shares reported herein as beneficially owned by (i) Abrams Capital, LLC ("Abrams Capital") represent shares held for the account of Abrams Capital Partners II, L.P. ("ACP II") and other private investment funds for which Abrams Capital serves as general partner; and (ii) Riva Capital Management III, LLC ("RCM III") represent shares held for the account of Riva Capital Partners III, L.P. ("Riva III"), for which RCM III serves as general partner. Shares reported herein for Abrams Capital Management, L.P. (the "LP") and Abrams Capital Management, LLC (the "LLC") represent shares beneficially owned by private investment funds for which the LP serves as investment manager, including ACP II and Riva III. The LLC is the general partner of the LP. Shares reported herein for Mr. Abrams represent the above referenced shares reported for Abrams Capital, RCM III and the LLC. Mr. Abrams is the managing member of Abrams Capital, RCM III, and the LLC. F3 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or his pecuniary interest in such shares, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purpose. F4 · ownership.nature: Of the shares sold on February 8, 2021, 41,063 shares were held for the account of ACP II; 36,868 shares were held for the account of Riva III; RCM III may be deemed to beneficially own 36,868 shares; Abrams Capital may be deemed to beneficially own 48,595 shares; and all such shares may be deemed to have been beneficially owned by Mr. Abrams, the LP and the LLC. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 00:00 UTC |
Gordon StephenChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,429 | $0.00 Strike: $0.67 | $0.00 |
DisclosureSEC source: 0000899243-21-005748 · doc4.xml · derivative · entry 4 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,713 Underlying: Common Stock · 1,429 shares Expires 2025-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · derivative.exercise_date: The option is fully vested. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 00:00 UTC |
Gordon StephenChief Financial Officer
|
SaleCommon Stock | 1,429 | $25.01 | $35,739.29 |
DisclosureSEC source: 0000899243-21-005748 · doc4.xml · nonDerivative · entry 3 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 00:00 UTC |
Gordon StephenChief Financial Officer
|
Exercise / conversionCommon Stock | 1,429 | $0.67 | $957.43 |
DisclosureSEC source: 0000899243-21-005748 · doc4.xml · nonDerivative · entry 2 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,429 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 00:00 UTC |
Gordon StephenChief Financial Officer
|
SaleCommon Stock | 8,571 | $25.01 | $214,360.71 |
DisclosureSEC source: 0000899243-21-005748 · doc4.xml · nonDerivative · entry 1 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 02:00 UTC |
Sullivan John FVP of Quality & Engineering
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 9,617 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0000899243-21-002615 · doc4.xml · derivative · entry 3 Sullivan John F · CIK 0001774273 · VP of Quality & Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 9,617 shares Expires 2021-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 02:00 UTC |
Sullivan John FVP of Quality & Engineering
|
SaleCommon Stock | 9,617 | $22.12 | $212,728.04 |
DisclosureSEC source: 0000899243-21-002615 · doc4.xml · nonDerivative · entry 2 Sullivan John F · CIK 0001774273 · VP of Quality & Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,828 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $21.99 to $22.55 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 02:00 UTC |
Sullivan John FVP of Quality & Engineering
|
Exercise / conversionCommon Stock | 9,617 | $0.39 | $3,750.63 |
DisclosureSEC source: 0000899243-21-002615 · doc4.xml · nonDerivative · entry 1 Sullivan John F · CIK 0001774273 · VP of Quality & Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,445 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 05, 2021 Filed Jan 14, 2021 23:56 UTC |
Hassanein Waleed HDirector · President & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 123,414 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0000899243-21-002088 · doc4.xml · derivative · entry 2 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 123,414 shares Expires 2021-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is fully vested. Read SEC document |
| January 05, 2021 Filed Jan 14, 2021 23:56 UTC |
Hassanein Waleed HDirector · President & CEO
|
Exercise / conversionCommon Stock | 123,414 | $0.39 | $48,131.46 |
DisclosureSEC source: 0000899243-21-002088 · doc4.xml · nonDerivative · entry 1 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,843 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 23:04 UTC |
Gordon StephenChief Financial Officer
|
SaleCommon Stock | 1,184 | $20.00 | $23,680.00 |
DisclosureSEC source: 0000899243-21-000439 · doc4.xml · nonDerivative · entry 2 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,371 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 22:57 UTC |
RAINES MERILEEDirector
|
GrantStock Option (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $19.90 | $0.00 |
DisclosureSEC source: 0000899243-21-000436 · doc4.xml · derivative · entry 1 RAINES MERILEE · CIK 0001023869 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2031-01-01 F1 · derivative.exercise_date: The option vests as to one-third of the shares subject to the option on the first anniversary of the date of grant and in equal monthly installments as to the remainder of the shares for two years thereafter. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 23:04 UTC |
Gordon StephenChief Financial Officer
|
SaleCommon Stock | 8,816 | $20.00 | $176,320.00 |
DisclosureSEC source: 0000899243-21-000439 · doc4.xml · nonDerivative · entry 1 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,755 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| December 21, 2020 Filed Dec 22, 2020 21:19 UTC |
Sullivan John FVP of Quality & Engineering
|
SaleCommon Stock | 1,000 | $17.99 | $17,990.00 |
DisclosureSEC source: 0000899243-20-034833 · doc4.xml · nonDerivative · entry 1 Sullivan John F · CIK 0001774273 · VP of Quality & Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,828 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $17.66 to $18.35 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 16, 2020 Filed Dec 17, 2020 22:57 UTC |
Sullivan John FVP of Quality & Engineering
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0000899243-20-034318 · doc4.xml · derivative · entry 5 Sullivan John F · CIK 0001774273 · VP of Quality & Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,617 Underlying: Common Stock · 1,000 shares Expires 2021-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| December 16, 2020 Filed Dec 17, 2020 22:57 UTC |
Sullivan John FVP of Quality & Engineering
|
Exercise / conversionCommon Stock | 1,000 | $0.39 | $390.00 |
DisclosureSEC source: 0000899243-20-034318 · doc4.xml · nonDerivative · entry 3 Sullivan John F · CIK 0001774273 · VP of Quality & Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,828 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 22:57 UTC |
Sullivan John FVP of Quality & Engineering
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0000899243-20-034318 · doc4.xml · derivative · entry 4 Sullivan John F · CIK 0001774273 · VP of Quality & Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,617 Underlying: Common Stock · 3,000 shares Expires 2021-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 22:57 UTC |
Sullivan John FVP of Quality & Engineering
|
SaleCommon Stock | 3,000 | $16.63 | $49,890.00 |
DisclosureSEC source: 0000899243-20-034318 · doc4.xml · nonDerivative · entry 2 Sullivan John F · CIK 0001774273 · VP of Quality & Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,828 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $16.50 to $16.81 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 22:57 UTC |
Sullivan John FVP of Quality & Engineering
|
Exercise / conversionCommon Stock | 3,000 | $0.39 | $1,170.00 |
DisclosureSEC source: 0000899243-20-034318 · doc4.xml · nonDerivative · entry 1 Sullivan John F · CIK 0001774273 · VP of Quality & Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,828 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| December 11, 2020 Filed Dec 14, 2020 21:53 UTC |
Provost MiriamVP of US Regulatory & FDA Rel.
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,600 | $0.00 Strike: $3.22 | $0.00 |
DisclosureSEC source: 0000899243-20-033750 · doc4.xml · derivative · entry 2 Provost Miriam · CIK 0001773663 · VP of US Regulatory & FDA Rel. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,971 Underlying: Common Stock · 4,600 shares Expires 2028-04-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested 25% on the first anniversary of the vesting commencement date, February 20, 2018, and will vest at a rate of 2.0833% each month thereafter until the option is fully vested on the fourth anniversary of the vesting date. Read SEC document |
| December 11, 2020 Filed Dec 14, 2020 21:53 UTC |
Provost MiriamVP of US Regulatory & FDA Rel.
|
Exercise / conversionCommon Stock | 4,600 | $3.22 | $14,812.00 |
DisclosureSEC source: 0000899243-20-033750 · doc4.xml · nonDerivative · entry 1 Provost Miriam · CIK 0001773663 · VP of US Regulatory & FDA Rel. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2020 Filed Sep 3, 2020 22:41 UTC |
Carey John FVP of Operations
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0000899243-20-024190 · doc4.xml · derivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,000 shares Expires 2021-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| September 01, 2020 Filed Sep 3, 2020 22:41 UTC |
Carey John FVP of Operations
|
SaleCommon Stock | 2,000 | $17.59 | $35,180.00 |
DisclosureSEC source: 0000899243-20-024190 · doc4.xml · nonDerivative · entry 2 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,200 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $17.23 to $17.90 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 01, 2020 Filed Sep 3, 2020 22:41 UTC |
Carey John FVP of Operations
|
Exercise / conversionCommon Stock | 2,000 | $0.39 | $780.00 |
DisclosureSEC source: 0000899243-20-024190 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| August 03, 2020 Filed Aug 6, 2020 00:08 UTC |
Carey John FVP of Operations
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0000899243-20-021569 · doc4.xml · derivative · entry 4 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,331 Underlying: Common Stock · 2,000 shares Expires 2027-06-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The option vests as a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, June 22, 2017. Read SEC document |
| August 03, 2020 Filed Aug 6, 2020 00:08 UTC |
Carey John FVP of Operations
|
SaleCommon Stock | 142 | $18.96 | $2,692.32 |
DisclosureSEC source: 0000899243-20-021569 · doc4.xml · nonDerivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,200 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $18.90 to $19.02 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 03, 2020 Filed Aug 6, 2020 00:08 UTC |
Carey John FVP of Operations
|
SaleCommon Stock | 1,858 | $18.58 | $34,521.64 |
DisclosureSEC source: 0000899243-20-021569 · doc4.xml · nonDerivative · entry 2 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,342 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $17.90 to $18.88 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 03, 2020 Filed Aug 6, 2020 00:08 UTC |
Carey John FVP of Operations
|
Exercise / conversionCommon Stock | 2,000 | $2.21 | $4,420.00 |
DisclosureSEC source: 0000899243-20-021569 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 23:42 UTC |
Carey John FVP of Operations
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,106 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0000899243-20-018365 · doc4.xml · derivative · entry 6 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,331 Underlying: Common Stock · 1,106 shares Expires 2027-06-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F5 · derivative.exercise_date: The option vests as a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, June 22, 2017. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 23:42 UTC |
Carey John FVP of Operations
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 894 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0000899243-20-018365 · doc4.xml · derivative · entry 5 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 894 shares Expires 2021-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 23:42 UTC |
Carey John FVP of Operations
|
SaleCommon Stock | 600 | $17.92 | $10,752.00 |
DisclosureSEC source: 0000899243-20-018365 · doc4.xml · nonDerivative · entry 4 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,200 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $17.59 to $18.27 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.